Michael Morrissey
Chief Executive Officer at EXELIXIS, INC.
Net worth: 59 M $ as of 31/03/2024
Profile
Currently, Michael M. Morrissey occupies the position of President, Chief Executive Officer & Director at Exelixis, Inc. Dr. Morrissey is also on the board of XWPharma Ltd. In his past career Dr. Morrissey occupied the position of Senior Scientist at Ciba-Geigy Corp. and Vice President-Discovery Research at Berlex Biosciences. Michael M. Morrissey received a doctorate from Harvard University and an undergraduate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.82% | 23/02/2024 | 2,492,969 ( 0.82% ) | 59 M $ | 31/03/2024 |
| 18/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Michael Morrissey active positions
| Companies | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Chief Executive Officer | 22/07/2010 |
| VERA THERAPEUTICS, INC. | Chairman | 24/05/2022 |
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16/12/2020 |
Former positions of Michael Morrissey
| Companies | Position | End |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01/11/2022 |
| Berlex Biosciences | Corporate Officer/Principal | 01/01/2000 |
| Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01/01/1991 |
Training of Michael Morrissey
| Harvard University | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| VERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Michael Morrissey
